BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

EGALET US INC.

via THE MCMANUS GROUP

3rd Quarter (July 1 - Sep 30) · 2017Posted Oct 19, 2017Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: EGALET US INC.
Description: Pharmaceutical company that develops and commercializes abuse-deterrent formulations.
Location: Pennsylvania · United States of America

Registrant

Firm: THE MCMANUS GROUP
Description: Consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Advocated for access to abuse-deterrent formulations.
LobbyistsJOHN MCMANUS · BARRETT THORNHILL · CHRISTINA HOCHUL
Covered position (JOHN MCMANUS): Staff Director W&M; LA, Rep. Bill Thomas
Covered position (BARRETT THORNHILL): LA, Sen. Crapo & Rep. Toomey; LA & Press Sec. Rep. Norwood
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

EGALET US INC. — Lobbying — Receipts Report